Walgreens Boots Alliance Inc (WBA) Shares Sold by APG Asset Management N.V.
APG Asset Management N.V. trimmed its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 19.0% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 2,465,680 shares of the pharmacy operator’s stock after selling 579,000 shares during the quarter. APG Asset Management N.V. owned approximately 0.23% of Walgreens Boots Alliance worth $190,400,000 as of its most recent SEC filing.
Several other hedge funds have also recently modified their holdings of the company. Pathstone Family Office LLC grew its stake in Walgreens Boots Alliance by 226.6% in the 2nd quarter. Pathstone Family Office LLC now owns 1,179 shares of the pharmacy operator’s stock valued at $1,969,000 after buying an additional 818 shares during the last quarter. Hudock Capital Group LLC grew its stake in Walgreens Boots Alliance by 0.5% in the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after buying an additional 6 shares during the last quarter. Westside Investment Management Inc. grew its stake in Walgreens Boots Alliance by 10.4% in the 2nd quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock valued at $102,000 after buying an additional 125 shares during the last quarter. Bristlecone Advisors LLC acquired a new position in Walgreens Boots Alliance in the 3rd quarter valued at about $135,000. Finally, Hanson McClain Inc. grew its stake in Walgreens Boots Alliance by 4.6% in the 2nd quarter. Hanson McClain Inc. now owns 1,987 shares of the pharmacy operator’s stock valued at $156,000 after buying an additional 87 shares during the last quarter. 60.24% of the stock is currently owned by institutional investors.
WBA has been the topic of a number of research reports. Jefferies Group reiterated a “buy” rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a research note on Monday, October 2nd. Needham & Company LLC reiterated a “buy” rating and issued a $94.00 price target on shares of Walgreens Boots Alliance in a research note on Saturday, September 16th. Loop Capital initiated coverage on shares of Walgreens Boots Alliance in a research note on Thursday, August 24th. They issued a “buy” rating and a $95.00 price target on the stock. UBS reiterated a “buy” rating and issued a $96.00 price target (down previously from $97.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, August 23rd. Finally, Mizuho set a $94.00 price target on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Tuesday, October 24th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and fourteen have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $86.47.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The company had revenue of $30.15 billion during the quarter, compared to the consensus estimate of $29.93 billion. During the same quarter in the prior year, the firm posted $1.07 EPS. The firm’s quarterly revenue was up 5.3% on a year-over-year basis. research analysts forecast that Walgreens Boots Alliance Inc will post 5.54 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.24%. The ex-dividend date of this dividend is Friday, November 10th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 42.33%.
Walgreens Boots Alliance declared that its Board of Directors has approved a stock buyback plan on Wednesday, October 25th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the pharmacy operator to buy shares of its stock through open market purchases. Shares repurchase plans are generally an indication that the company’s board of directors believes its shares are undervalued.
In other news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the completion of the sale, the director now owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director John Anthony Lederer purchased 20,000 shares of the business’s stock in a transaction dated Thursday, October 26th. The shares were purchased at an average cost of $67.00 per share, with a total value of $1,340,000.00. Following the acquisition, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. The disclosure for this purchase can be found here. Corporate insiders own 14.80% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This article was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/12/10/walgreens-boots-alliance-inc-wba-shares-sold-by-apg-asset-management-n-v.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Stock Ratings for Walgreens Boots Alliance Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc and related stocks with our FREE daily email newsletter.